COVID-19 vaccine | SII secures purchase order for Covishield from Indian government

The Serum Institute of India (SII) has signed a purchase order with the Government of India to procure 11 million doses of coronavirus vaccines.

Serum Institute of India officials said on January 11: "The SII has received purchase order from Government of India."

As per the purchase order, each dose of the coronavirus vaccine will cost Rs 220 inclusive of 14 percent GST. SII is manufacturing Oxford-AstraZeneca's COVID-19 vaccine Covishield in India. For live updates on coronavirus, click here

The dispatch of the COVID-19 vaccines being manufactured by SII in India will begin on January 11 evening, News 18 reported. The Mumbai airport will be handling over half of the Covishield vaccines coming from SII's Pune facility. Mumbai International Airport Ltd (MIAL)'s Chief Executive Officer Rajeev Jain has told Moneycontrol: "The Mumbai airport will be catering to Serum Institute of India (SII). While the Pune airport will handle about 40-45 percent of the volumes, MIAL will distribute the rest."